Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Clinical trial NCT00521339 · COMPLETED
Trial details
- NCT number
- NCT00521339
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-04-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.